Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
State Policy · CAAugust 17, 2026

California State-Branded Insulin Launch Lags Despite Newsom Promotion

California launched CalRx, the nation's first state-branded insulin product, as part of Governor Gavin Newsom's effort to lower drug costs by disrupting the pharmaceutical market. The generic insulin label has experienced slow distribution to pharmacies and limited patient access since its introduction. The initiative aims to provide affordable insulin alternatives for California residents, including Medicaid beneficiaries who rely on the drug for diabetes management. The delayed rollout raises questions about the viability of state-manufactured or state-branded pharmaceutical programs as cost-containment strategies.

Why it mattersCalifornia Medicaid covers approximately 350,000 insulin users, and delayed CalRx availability affects the state's ability to reduce pharmacy spending and improve access for beneficiaries with diabetes.

Pharmacy

Read the full article at kffhealthnews.org →
Share this briefing

You might also like

← All stories

Get the daily briefing.